Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 77 of 102, showing 5 Applications out of 510 total, starting on record 381, ending on 385

# Protocol No Study Title Investigator(s) & Site(s)

381.

ECCT/16/07/06   Cups or Cash for Girls Trial
    Menstrual cups and cash transfer to reduce sexual and reproductive harm and school dropout in adolescent schoolgirls in western Kenya: a cluster randomised controlled trial   
Principal Investigator(s)
1. Penelope Anne Phillips-Howard
2. Daniel Oluoch Kwaro
Site(s) in Kenya
Siaya County
 
View

382.

ECCT/16/07/05   HESTIA 1
    Multicentre, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric patients with sickle cell disease   
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Kemri CRDR research center at Chandaria Health Centre Dagoretti (Nairobi City county)
3. Clinical Research Annex at the Siaya County Referral Hospital (Siaya county)
4. Kondele Children’s Hospital, KEMRI – Centre for Clinical Research (Kisumu county)
 
View

383.

ECCT/16/07/03   CYP STUDY
    Primaquine metabolism and its association with CYP2D6 and CYP2C19 genotypes among adults living within Seme and Kisumu West sub-counties of Kisumu County, Western Kenya       
Principal Investigator(s)
1. BEN ANDAGALU
2. BEN ANDAGALU
Site(s) in Kenya
KOMBEWA CLINICAL RESEARCH CENTRE
 
View

384.

ECCT/16/07/02   A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events
    A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events   
Principal Investigator(s)
1. Mark Loeb
Site(s) in Kenya
The Aga Khan University Hospital
 
View

385.

ECCT/16/07/01   VAC52150EBL4001
    A Multi-country, prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines AD26.ZEBOV and or/ MVA-BN-Filo   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Kenya medical Research Institute/Walter Reed Project Kombewa (Kisumu county)
3. Kenya medical Research Institute/Walter Reed Project Kombewa (Kericho county)
 
View